2m 2m 2m 2m 2m 2m 2m
ORTHOFIX MED (OFIX)
NASDAQ
$9.72+$0.005 (+0.05%)
Price as of Jun 03, 2026 4:38 PM EDT- $374.7MMarket Cap
- -11.97%1-Year Change
- Medical DevicesIndustry
ORTHOFIX MED (OFIX)
$9.72+$0.005 (+0.05%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 822.3M +2.85% | 799.5M +7.08% | 746.6M +62.06% | 460.7M -0.81% | |
Cost of Revenue | 256.3M +1.06% | 253.6M -2.60% | 260.4M +110.75% | 123.5M +7.51% | |
Gross Profit | 566.0M +3.69% | 545.9M +12.26% | 486.3M +44.22% | 337.2M -3.55% | |
Sales and Marketing Expense | 554.3M +4.09% | 532.5M +38.05% | 385.7M +68.58% | 228.8M +3.39% | |
Research and Development Expense | -65.8M -10.59% | -73.6M -8.21% | -80.2M +63.52% | -49.1M -1.12% | |
Depreciation and Amortization Expense | 77.3M +28.74% | 60.1M +13.19% | 53.1M +82.86% | 29.0M -1.96% | |
Total Operating Expenses | 256.3M +1.06% | 253.6M -2.60% | 260.4M +110.75% | 123.5M +7.51% | |
Operating Profit | -81.4M -3.77% | -84.6M -39.17% | -139.1M +948.46% | -13.3M +59.57% | |
Interest Income | -48,000 -100.94% | 5.1M +187.48% | 1.8M N/A | N/A N/A | |
Interest Expense | -17.5M -40.98% | -29.6M +243.31% | -8.6M +570.11% | -1.3M -29.89% | |
Interest Income and Expense and Net | -17.5M -28.46% | -24.5M +257.82% | -6.8M +431.83% | -1.3M -29.89% | |
Total Nonoperating Income and Expense | 8.1M +184.22% | -9.6M +926.12% | -938,000 -70.22% | -3.1M -5.77% | |
Income before Taxes | -90.8M -26.69% | -123.9M -16.68% | -148.7M +739.71% | -17.7M +31.20% | |
Income Taxes | 1.4M -34.87% | 2.1M -21.87% | 2.7M +32.94% | 2.0M -91.79% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -92.2M -26.83% | -126.0M -16.78% | -151.4M +666.60% | -19.7M -48.54% | |
Net Income from Continuing Operations Applicable to Common | -90.8M -26.69% | -123.9M -16.68% | -148.7M +739.71% | -17.7M +31.20% | |
Basic EPS and Net Income | -2.33 -29.39% | -3.30 -19.90% | -4.12 +320.41% | -0.98 -49.74% | |
Diluted EPS and Net Income | -2.33 -29.39% | -3.30 -19.90% | -4.12 +320.41% | -0.98 -49.74% | |
Basic Weighted Average Shares | 39.6M +3.85% | 38.1M +3.82% | 36.7M +83.16% | 20.1M +1.84% | |
Diluted Weighted Average Shares | 39.6M +3.85% | 38.1M +3.82% | 36.7M +83.16% | 20.1M +1.84% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 82.0M -1.46% | 83.2M +151.42% | 33.1M -34.70% | 50.7M -42.29% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 82.0M -1.46% | 83.2M +151.42% | 33.1M -34.70% | 50.7M -42.29% | |
Total Current Assets | 416.8M -3.79% | 433.3M +3.05% | 420.4M +64.24% | 256.0M -5.02% | |
Accumulated Depreciation | 250.7M +18.14% | 212.2M +12.52% | 188.6M +15.72% | 163.0M -10.91% | |
Property and Plant and Equipment and Net | 129.4M -7.44% | 139.8M -12.11% | 159.1M +173.16% | 58.2M -1.73% | |
Total Long-Term Assets | 36.7M +38.67% | 26.5M -20.73% | 33.4M +29.89% | 25.7M +16.34% | |
Total Assets | 850.6M -4.77% | 893.3M -3.46% | 925.3M +101.76% | 458.6M -3.78% | |
Income Taxes Payable | 6.1M -51.87% | 12.6M +203.09% | 4.2M +232.01% | 1.3M +16.51% | |
Total Short-Term Debt | 0 -100.00% | 1.3M 0.00% | 1.3M -91.67% | 15.0M N/A | |
Total Current Liabilities | 170.5M +1.10% | 168.6M +2.06% | 165.2M +97.58% | 83.6M -20.98% | |
Total Long-Term Debt | 157.4M +0.24% | 157.0M +68.64% | 93.1M +365.54% | 20.0M +3,233.33% | |
Total Long-Term Liabilities | 55.7M +19.24% | 46.7M -6.10% | 49.7M +163.00% | 18.9M +35.34% | |
Total Liabilities | 400.6M +2.68% | 390.2M +19.47% | 326.6M +168.20% | 121.8M -12.83% | |
Retained Earnings | -368.3M +33.39% | -276.1M +83.92% | -150.1M -12,101.92% | 1.3M -94.04% | |
Total Stockholders Equity | 450.0M -10.55% | 503.1M -15.97% | 598.7M +77.74% | 336.9M -0.02% | |
Total Shares Outstanding | 39.8M +3.50% | 38.5M +3.55% | 37.2M +84.33% | 20.2M +1.64% | |
Cash Flow | |||||
Cash from Operating Activities | 33.3M +29.30% | 25.8M +156.37% | -45.8M +296.54% | -11.5M -162.45% | |
Capital Expenditures | 34.6M -0.72% | 34.9M -42.12% | 60.3M +182.04% | 21.4M +20.12% | |
Cash from Investing Activities | -34.6M +25.45% | -27.6M -16.75% | -33.1M +35.04% | -24.5M +6.61% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -786,000 -101.55% | 50.7M -22.37% | 65.3M +83,846.15% | -78,000 -97.85% | |
Financials Ratio | |||||
Gross Margin | 68.83% +0.81% | 68.28% +4.84% | 65.13% -11.01% | 73.18% -2.76% | |
Operating Margin | -9.90% -6.44% | -10.58% -43.19% | -18.63% +546.95% | -2.88% +60.87% | |
Return on Assets | -10.57% -23.70% | -13.86% -36.67% | -21.88% +418.06% | -4.22% -44.84% | |
Return on Equity | -19.34% -15.42% | -22.87% -29.33% | -32.36% +452.09% | -5.86% -47.01% | |
Revenue Growth | 2.85% -59.67% | 7.08% -88.59% | 62.06% +7,754.43% | -0.81% -105.69% | |
Current Ratio | 2.45 -4.84% | 2.57 +0.97% | 2.54 -16.87% | 3.06 +20.20% | |
Cash Ratio | 0.48 -2.53% | 0.49 +146.31% | 0.20 -66.95% | 0.61 -26.96% | |
Debt-to-Equity Ratio | 0.35 +11.16% | 0.31 +99.62% | 0.16 +51.68% | 0.10 +5,672.22% | |
Debt-to-Assets Ratio | 0.19 +4.40% | 0.18 +73.73% | 0.10 +33.68% | 0.08 +5,769.23% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow